A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition
暂无分享,去创建一个
D. Macmahon | A. Johnston | T. Corn | S. Warrington | M. Boyce | A. Clarke | E. S. Johnson | N. Mallard | D. MacMahon | Atholl Johnston | Malcolm Boyce | SJ Warrington